Literature DB >> 25473030

Late repair of tetralogy of Fallot during childhood in patients from developing countries.

Nadir Benbrik1, Bénédicte Romefort1, Laurianne Le Gloan1, Karine Warin1, Quentin Hauet1, Patrice Guerin1, Olivier Baron2, Véronique Gournay3.   

Abstract

OBJECTIVES: Although the current surgical approach of tetralogy of Fallot (TOF) is primary complete repair in infancy, late diagnosis and lack of surgical facilities in developing countries may delay surgical treatment. Some of these patients exposed to prolonged chronic hypoxaemia are transferred to more privileged countries to undergo surgical repair with the support of non-governmental organizations. The objective of this single-centre retrospective study was to compare the postoperative outcomes of these foreign patients undergoing delayed repair with those of patients born in France undergoing timely repair during the same time period.
METHODS: The computer database of our institution was searched for all cases of TOF in foreign patients younger than 15 years, supported by two non-profit organizations, who underwent complete repair between January 2007 and December 2013. The control population consisted of the patients with TOF born in France, who underwent timely complete repair during the same period.
RESULTS: The 47 foreign children were older (57.6 ± 38.4 vs 8.3 ± 9.1 months, P < 0.0001), more hypoxaemic (SaO2 79 ± 11 vs 91 ± 8%, P < 0.0001), more growth-retarded (body mass index Z-score -1.35 ± 1.5 vs -0.46 ± 1.3, P = 0.0034), and had higher haematocrit level (52.5 ± 11.7 vs 37.5 ± 6.1%, <0.0001) and worse left ventricular ejection fraction (LVEF 62 ± 8 vs 69 ± 3.8%, P < 0.0001) than the 90 French patients. Postoperative mortality and morbidity (sepsis, arrhythmia, bleeding and need for surgical revision) were similar in the two groups, except for a higher rate of pericardial and/or pleural effusion in foreign children (36 vs 17%, P = 0.02). Length of stay was shorter in foreign than in French patients (11 ± 6 vs 15 ± 15 days, P = 0.0012).
CONCLUSIONS: In our experience, despite the presence of several risk factors (growth retardation, chronic hypoxaemia, polycythaemia and left ventricular dysfunction), late repair of TOF was undertaken during childhood in patients from developing countries with no difference in postoperative morbidity and mortality compared with that of timely repair during infancy. These older patients can be discharged sooner. However, patients undergoing late surgery may be at higher risk of complications of right ventricular failure, such as pleural and/or pericardial effusion.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Delayed repair; Paediatrics; Tetralogy of Fallot

Mesh:

Year:  2014        PMID: 25473030     DOI: 10.1093/ejcts/ezu469

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Unrepaired Tetralogy of Fallot with Absent Pulmonary Valve in a Mildly Symptomatic 16-Year-Old Boy.

Authors:  Diana E Drogalis-Kim; Brian L Reemtsen; Leigh Christopher Reardon
Journal:  Tex Heart Inst J       Date:  2016-12-01

2.  Tetralogy of Fallot repair in patients presenting after Infancy: A single surgeon experience.

Authors:  Tariq Waqar; Muhammad Usman Riaz; Tania Mahar
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

Review 3.  Current Strategies to Optimize Nutrition and Growth in Newborns and Infants with Congenital Heart Disease: A Narrative Review.

Authors:  Guglielmo Salvatori; Domenico Umberto De Rose; Anna Claudia Massolo; Neil Patel; Irma Capolupo; Paola Giliberti; Melania Evangelisti; Pasquale Parisi; Alessandra Toscano; Andrea Dotta; Giovanni Di Nardo
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

4.  Investigation of associated factors with post-operative outcomes in patients undergoing Tetralogy of Fallot correction.

Authors:  Ahmad Ali Amirghofran; Jamshid Badr; Mansour Jannati
Journal:  BMC Surg       Date:  2018-03-15       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.